Abciximab. An updated review of its use in ischaemic heart disease (Q33504164)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Abciximab. An updated review of its use in ischaemic heart disease	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9806109

retrieved

27 July 2017

review article

1 reference

stated in

Europe PubMed Central

title

Abciximab. An updated review of its use in ischaemic heart disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9806109

retrieved

27 July 2017

main subject

arteriosclerotic heart disease

1 reference

based on heuristic

inferred from title

author name string

R H Foster

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9806109

retrieved

27 July 2017

L R Wiseman

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9806109

retrieved

27 July 2017

publication date

1 October 1998

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9806109

retrieved

27 July 2017

published in

Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9806109

retrieved

27 July 2017

volume

56

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9806109

retrieved

27 July 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9806109

retrieved

27 July 2017

page(s)

629-665

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9806109

retrieved

27 July 2017

cites work

Overview of clinical trials with glycoprotein IIb-IIIa receptor antagonists in the prevention and management of coronary

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: Implications for inhibition of the internal pool of GPIIb/IIIa receptors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. EPIC Investigators

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of abciximab in interventional cardiology

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safe use of platelet GP IIb/IIIa inhibitors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part I).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of c7E3 Fab in conjunction with primary coronary stenting for acute myocardial infarctions complicated by cardiogenic shock

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of platelets and white blood cells and antiplatelet agent C7E3 (Reopro) on a new test of PAF procoagulant activity of whole blood

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Compl

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness and cost effectiveness of single bolus treatment with abciximab (Reo Pro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of platelets in restenosis after percutaneous coronary revascularization

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Economics of IIb/IIIa Therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgery. EPIC Investigators. Evaluation Prevention of Ischemic Complications

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

"Rescue" utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness analysis of abciximab: a Canadian hospital perspective

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The future of interventional cardiology

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restenosis: the cost to society.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Description of an In Vitro Platelet Function Analyzer-PFA-100™

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (Abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abciximab therapy in percutaneous intervention: economic issues in the United States

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dissociation between the anti-aggregatory & anti-secretory effects of platelet integrin alpha IIb beta 3 (GPIIb/IIIa) antagonists, c7E3 and DMP728

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Routine use of abciximab in coronary stenting?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advances in coronary angioplasty

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (Mac-1)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation in support of national health policy: the case of The Netherlands

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abciximab and excessive bleeding in patients undergoing emergency cardiac operations

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical experience with abciximab during coronary revascularisation: an overview

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelets and thrombolytic therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Clinical Impact of Platelet Glycoprotein IIb/IIIa Receptor Blockade in Cardiovascular Medicine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombosis in ischemic heart disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased Risk of Non-Q Wave Myocardial Infarction After Directional Atherectomy Is Platelet Dependent: Evidence From the EPIC Trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycoprotein IIb/IIIa blockade inhibits platelet-mediated force development and reduces gel elastic modulus.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy. EPILOG Investigators. Evaluation of PTCA to Improve Long-term Outcome by c7E3 GP IIb/IIIa Recepto

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Costs and effects in therapy for acute coronary syndromes: the case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study. Evaluation of 7E3 for the Prevention of Ischemic Complications

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does Intracoronary Thrombus Influence the Outcome of High Risk Percutaneous Transluminal Coronary Angioplasty? Clinical and Angiographic Outcomes in a Large Multicenter Trial fn1fn1This study was suppported by a grant from Centocor, Inc

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Costs and effects of c7E3 in high risk PTCA patients. An indirect analysis for The Netherlands

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Using cost-effectiveness for subsidy decisions.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cone and plate(let) analyzer: monitoring glycoprotein IIb/IIIa antagonists and von Willebrand disease replacement therapy by testing platelet deposition under flow conditions.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emergency coronary bypass grafting for failed percutaneous coronary artery stenting: increased costs and platelet transfusion requirements after the use of abciximab

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary artery stenting during acute myocardial infarction in patients treated with IIb/IIIa anti-platelet antibodies: early outcome results

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Clinical safety using the thrombocyte aggregation inhibitor c7E3 in interventional cardiology in 520 patients]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abciximab-induced thrombopenia during treatment of acute coronary syndromes by angioplasty

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abciximab-associated profound thrombocytopenia: therapy with immunoglobulin and platelet transfusion

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Partial reversal of heparin anticoagulation by intravenous protamine in abciximab-treated patients undergoing percutaneous intervention

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stenting and IIb/IIIa Receptor Blockade in Acute Myocardial Infarction: An Introduction to the CADILLAC Trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A modified thromboelastographic method for monitoring c7E3 Fab in heparinized patients.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonist c7E3 Fab on the activated clotting time

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enthusiasm, reality, and cost-effectiveness analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term clinical follow-up in patients with angiographic restudy after successful angioplasty.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abciximab (c7E3 Fab). A review of its pharmacology and therapeutic potential in ischaemic heart disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The glycoprotein IIb/IIIa antagonist c7E3 inhibits platelet aggregation in the presence of heparin-associated antibodies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meeting highlights: highlights of the 70th Scientific Sessions of the American Heart Association

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of anti-GP IIb-IIIa in acute thrombosis after intracoronary stent implantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Benefit within Patient Subgroups Receiving c7E3 Fab (Abciximab) During Percutaneous Coronary Revascularization: Subgroup Analysis from the EPIC Trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators. Observations in animals and humans

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial). Evaluation of c7E3 Fab in the Prevention of Ischemic Complicatio

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring platelet GP IIb/IIIa antagonist therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies to platelet glycoprotein IIb/IIIa as antithrombotic agents

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9806109

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00003495-199856040-00014

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9806109

retrieved

27 July 2017

Dimensions Publication ID

1011835891

0 references

PubMed publication ID

9806109

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9806109

retrieved

27 July 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33504164&oldid=2195425136"